CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
利用 CRISPR/Cas9 技术编辑 NKG2A 可提高原代 CD33 靶向嵌合抗原受体自然杀伤细胞的疗效
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-52388-1
Tobias Bexte # ,Nawid Albinger # ,Ahmad Al Ajami ,Philipp Wendel ,Leon Buchinger ,Alec Gessner ,Jamal Alzubi ,Vinzenz Särchen ,Meike Vogler ,Hadeer Mohamed Rasheed ,Beate Anahita Jung ,Sebastian Wolf ,Raj Bhayadia ,Thomas Oellerich ,Jan-Henning Klusmann ,Olaf Penack ,Nina Möker ,Toni Cathomen ,Michael A Rieger ,Katharina Imkeller ,Evelyn Ullrich